ad image

CMC

1 / 3
Fast Path to Market: Going from GMP1 to PPQ in Just 12 Months
PPQ

Fast Path to Market: Going from GMP1 to PPQ in Just 12 Months

Jessica Feldman, Ph.D.; Henning Gerschewski

Rentschler Biopharma SE

PAO-10-24-CL-12Dec 02, 2024
Revolutionary CDMO Wheeler Bio Appoints Patrick Lucy as CEO
CDMO

Revolutionary CDMO Wheeler Bio Appoints Patrick Lucy as CEO

David Alvaro, Ph.D.

Pharma's Almanac

PAO-10-24-CL-08Oct 11, 2024
Mitigating Early Development Risks with Samsung Biologics DEVELOPICK™ Platform
Developability

Mitigating Early Development Risks with Samsung Biologics DEVELOPICK™ Platform

Heonchang Lim

Samsung Biologics

PAO-09-24-CL-04Sep 04, 2024
Radical Bioprocessing Efficiencies and Cost Reductions — The Next Wave of Biopharmaceutical Innovation
Digitalization

Radical Bioprocessing Efficiencies and Cost Reductions — The Next Wave of Biopharmaceutical Innovation

Michael Sokolov, Ph.D.

DataHow

PAO-08-24-CL-02Aug 26, 2024
IND Enablement and Drug Product Development – Mitigating Risk and Accelerating through the "Valley of Death"
IND Enablement

IND Enablement and Drug Product Development – Mitigating Risk and Accelerating through the "Valley of Death"

Johannes Clemens

Coriolis Pharma

PAO-08-24-CL-07Aug 16, 2024
Rethinking the Conventional CDMO Model
CDMO Model

Rethinking the Conventional CDMO Model

Wheeler Bio

PAO-08-24-CL-04Jul 29, 2024
Overcoming Variability and Scaling Challenges in AAV Manufacturing
AAV

Overcoming Variability and Scaling Challenges in AAV Manufacturing

Rafal Garus

Viralgen Vector Core

PAO-08-24-CL-03Jul 22, 2024
Biotech Training is a Challenge
Training

Biotech Training is a Challenge

April Stanley, MS MBA; Koey Keylon

Nice Insight

PAO-06-24-NI-01Jun 11, 2024
Leveraging Innovative Transposase Technology for a Highly Reliable and Productive CMC Platform
Leap-In Transposase

Leveraging Innovative Transposase Technology for a Highly Reliable and Productive CMC Platform

Wheeler Bio

PAO-06-24-CL-05May 30, 2024
How Synergistic Collaborations Between Outsourcing Partners Can Accelerate Clinical Success
The PHASE Platform

How Synergistic Collaborations Between Outsourcing Partners Can Accelerate Clinical Success

Wheeler Bio

PAO-05-24-CL-01May 08, 2024
Right from the Start: Designing Advanceable Formulations and Processes at Phase I
Advanceability

Right from the Start: Designing Advanceable Formulations and Processes at Phase I

Serán Bioscience

PAO-02-24-CL-09Feb 26, 2024
Revolutionizing Early-Stage Biopharma Development: Introducing Wheeler Bio's Portable CMC® Platform
CMC

Revolutionizing Early-Stage Biopharma Development: Introducing Wheeler Bio's Portable CMC® Platform

Wheeler Bio

PAO-12-23-CL-04Feb 08, 2024
Podcast: Insights from CDO Experts from Samsung Biologics
Drug Development

Podcast: Insights from CDO Experts from Samsung Biologics

Jiyeon Lee; Hyelyoung Jang

Samsung Biologics

POD-01-24-CL-01Jan 16, 2024
S-Glyn™ : Optimizing N-Glycan Profiles and their Effector Functions Using a Design-of-Experiments Approach
Glycosylation

S-Glyn™ : Optimizing N-Glycan Profiles and their Effector Functions Using a Design-of-Experiments Approach

Junyong Park

Samsung Biologics

PAO-12-23-CL-06Dec 14, 2023
Designing A Recipe for Stem Cell Therapy Success
Stem Cell Therapy

Designing A Recipe for Stem Cell Therapy Success

Ben Josey, Ph.D.; Robert Padilla

Corning Life Sciences

PTV-12-23-CL-01Dec 12, 2023
Scaling Cell and Gene Therapy Processes from R&D to Production
Cell and Gene Therapy

Scaling Cell and Gene Therapy Processes from R&D to Production

Shawn Bates; Antonio Fernandez-Perez, Ph.D.

Corning Life Sciences

PAO-12-23-CL-03Dec 12, 2023
Market Trends Driving the Embrace of Plant-Based Cell-Culture Media Ingredients
Cell Culture Media

Market Trends Driving the Embrace of Plant-Based Cell-Culture Media Ingredients

Chris Wiedel

Nu-Tek BioSciences

PAO-10-23-CL-01Dec 06, 2023
Enabling Controlled End-to-End Biomanufacturing with Animal-Free Culture Media Products
Cell Culture Media

Enabling Controlled End-to-End Biomanufacturing with Animal-Free Culture Media Products

Thomas Yezzi

Nu-Tek BioSciences

PAO-08-23-CL-05Nov 14, 2023
Wheeler Bio

Alloy Therapeutics and Wheeler Bio Announce Preferred Service Offering for Alloy Partners to Accelerate the Translation from Discovery to CMC

Wheeler Bio

PR-M11-23-01Nov 08, 2023
Samsung Biologics
Strategic Partnership

Samsung Biologics and Kurma Partners Announce Strategic Partnership for Development and Manufacturing of Biologics for Kurma’s Portfolio Companies

Samsung Biologics

PR-M10-23-06Oct 24, 2023
1 / 3